Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$539M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$365M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$361M |
| 4 |
Charter Communications
CHTR
|
+$349M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$283M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$230M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.94% |
| 2 | Healthcare | 5.53% |
| 3 | Financials | 5.03% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Vaxcyte
PCVX
$7.65B
| $3.73M | ﹤0.01% |
155,439
+99,373
| +177% | +$2.52M |
|
1702
PUT
Sarepta Therapeutics
SRPT
$1.64B
| $3.73M | ﹤0.01% |
+33,700
| New | +$3.4M |
|
1703
CALL
Alcon
ALC
$34B
| $3.72M | ﹤0.01% |
+63,000
| New | +$4.37M |
|
1704
Green Plains
GPRE
$1.15B
| $3.72M | ﹤0.01% |
127,929
+7,218
| +6% | +$244K |
|
1705
CALL
FedEx
FDX
$73.3B
| $3.71M | ﹤0.01% |
25,000
| – | – |
|
1706
Li Auto
LI
$14.4B
| $3.7M | ﹤0.01% |
160,971
-88,603
| -36% | -$2.76M |
|
1707
CALL
Philip Morris
PM
$311B
| $3.7M | ﹤0.01% |
+44,600
| New | +$4.25M |
|
1708
PUT
Halliburton
HAL
$26.1B
| $3.69M | ﹤0.01% |
150,000
-350,000
| -70% | -$10M |
|
1709
Bausch Health
BHC
$1.68B
| $3.68M | ﹤0.01% |
529,640
+296,856
| +128% | +$2.06M |
|
1710
CALL
Rhythm Pharmaceuticals
RYTM
$7.34B
| $3.67M | ﹤0.01% |
+150,000
| New | +$2.79M |
|
1711
Organon & Co
OGN
$3.56B
| $3.67M | ﹤0.01% |
156,712
+68,147
| +77% | +$2.06M |
|
|
1712
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$32.3B
| $3.66M | ﹤0.01% |
+44,200
| New | +$4.07M |
|
1713
California Resources
CRC
$4.47B
| $3.66M | ﹤0.01% |
95,145
+10,260
| +12% | +$446K |
|
1714
Zentalis Pharmaceuticals
ZNTL
$325M
| $3.66M | ﹤0.01% |
168,815
+37,965
| +29% | +$1.04M |
|
1715
Ligand Pharmaceuticals
LGND
$5.79B
| $3.65M | ﹤0.01% |
67,906
+9,174
| +16% | +$539K |
|
1716
Trex
TREX
$4.41B
| $3.64M | ﹤0.01% |
82,890
+10,385
| +14% | +$556K |
|
|
1717
CALL
Charter Communications
CHTR
$17.1B
| $3.64M | ﹤0.01% |
12,000
| – | – |
|
1718
Enanta Pharmaceuticals
ENTA
$362M
| $3.64M | ﹤0.01% |
70,194
+4,444
| +7% | +$260K |
|
1719
Robinhood
HOOD
$80.6B
| $3.63M | ﹤0.01% |
359,446
-70,510
| -16% | -$678K |
|
1720
Regal Rexnord
RRX
$12.6B
| $3.63M | ﹤0.01% |
25,870
+9,124
| +54% | +$1.23M |
|
1721
DXC Technology
DXC
$1.89B
| $3.62M | ﹤0.01% |
148,009
-41,766
| -22% | -$1.15M |
|
1722
Agios Pharmaceuticals
AGIO
$2.08B
| $3.62M | ﹤0.01% |
127,920
-9,764
| -7% | -$262K |
|
1723
Columbia Banking Systems
COLB
$8.77B
| $3.62M | ﹤0.01% |
125,204
+2,019
| +2% | +$60.9K |
|
|
BRSL
1724
Brightstar Lottery PLC
BRSL
$1.89B
| $3.61M | ﹤0.01% |
228,665
+117,941
| +107% | +$2.21M |
|
|
VIVO
1725
DELISTED
Meridian Bioscience Inc
VIVO
| $3.6M | ﹤0.01% |
114,053
+88,644
| +349% | +$2.87M |
|
Similar funds
Citigroup's Q3 2022 Portfolio in Review
As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.
- Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
- Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
- Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
- Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
- Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
- Citigroup opened 321 new positions and closed 759 in Q3 2022.
- Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.